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The recrudescence and modification of radia- 
tion effects precipitated by the use of chemother- 
apeutic agents has been reported extensively in 
the literature. The recall of quiescent radiation ef- 
fects such as dermatitis, enteritis, esophagitis, 
pneumonitis, and mucositis has been most com- 
monly associated with dactinomycin (actinomy- 
tin D) and doxorubicin (Adriamycin, Adria Lab- 
oratories, Columbus, OH) therapy, although other 
chemotherapeutic agents have been implicated. 
Radiation recall supraglottitis has been reported 
previously in a 4i’-year-old adult with diffuse his- 
tiocytic lymphoma. We report the first case of ra- 
diation recall supraglottitis involving dactinomy- 
tin therapy in a child. 
CASE REPORT 
A &year-old white female initially presented at 2 
years of age with a rapidly enlarging mass in the right 
neck and right peripharyngeal space. Incisional biopsy 
at that time revealed pleomorphic rhabdomyosarcoma, 
and a tracheotomy was performed because of obstruc- 
tive apnea. A complete evaluation consisting of chest 
computed tomography scan, bone scan, lumbar punc- 
ture, and bone marrow biopsy revealed no evidence of 
systemic metastases or central nervous system involve- 
ment. The initial cervical computed tomography scan 
revealed a large right-sided peripharyngeal mass with 
areas of focal calcification and enhancement with con- 
trast infusion (Fig 1). The tumor was graded as group III 
according to the Intergroup Rhabdomyosarcoma Study I 
protocol (gross residual tumor) and the patient was be- 
gun on a therapeutic protocol consisting of dactinomy- 
tin, ifosfamide, and vincristine. The tumor failed to 
resolve completely and, in January 1989, a resection 
was performed for residual disease in the neck and pe- 
ripharyngeal space. The final pathology of the speci- 
men was consistent with pleomorphic rhabdomyosar- 
coma. Postoperatively, the patient received 60 Gy of 
hyperfractionated radiation therapy. A second, 2-week 
course of chemotherapy consisting of ifosfamide and 
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vincristine was initiated 1 month postoperatively. 
Three months postoperatively, the patient underwent 
microlaryngoscopy and bronchoscopy, which revealed 
a normal larynx with a small amount of inflammation 
in the posterior glottis. The subglottis was completely 
normal. The patient was subsequently decannulated 
without difficulty. 
One week after decannulation, the patient received 
further chemotherapy consisting of ifosfamide and vin- 
cristine and was discharged from the hospital. Four 
months after decannulation, she received further che- 
motherapy consisting of dactinomycin,vincristine, and 
ifosfamide. Soon after this course of chemotherapy, the 
patient developed increased airway obstruction with 
intermittent stridor. Her airway was felt to be stable 
with mild oxygen desaturation and was closely moni- 
tored at home with a pulse oximeter applied during 
sleep. 
As part of routine tumor surveillance, a magnetic res- 
onance imaging scan of the neck was obtained [Fig 2). A 
markedly decreased supraglottic airway was noted. In- 
creased signal intensity on T2 images of the supraglottic 
Figure I. Computed tomography scan of a large, right-sided 
peripharyngeal rhabdomyosarcoma. 
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Figure 2. Magnetic resonance imaging scan of the 
neck after the administration of dactinomycin. No- 
tice the fatty infiltration of cervical vertebrae 1-4 
on the Tl-weighted image, consistent with postra- 
diation changes. The significant edema noted in 
the supraglottic airway lies within the previous ra- 
diation ports. 
structures suggested edema rather than tumor infiltra- 
tion. In addition, increased signal intensity in vertebral 
bodies 1 to 5 coincided with the previous radiation 
therapy ports. The supraglottic larynx was noted to lie 
within the previous radiation port. The patient was re- 
admitted to the hospital at this time for microlaryngos- 
copy and bronchoscopy, which revealed marked epi- 
glottic and supraglottic edema (Fig 3, left). The glottis 
could not be identified. Under mask ventilation, a tra- 
cheotomy was performed without difficulty. 
Posttracheotomy laryngoscopy revealed a normal 
glottis (Fig 3, right). An epiglottic biopsy was obtained 
at this time and demonstrated inflammatory reaction. 
Microlaryngoscopy and bronchoscopy, performed 1 
month later, revealed persistence of the supraglottic 
edema, which was, however, decreased from the previ- 
Figure 3. (Left) Endoscopic appearance of supraglottis after administration of dactinomycin. (Right) The true vocal cords remain 
normal in appearance. 
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ous examination. Over the next year, the swelling in the 
supraglottic region decreased enough to allow decan- 
nulation. Subsequently, a stoma closure was required, 
but the child remains decannulated with normal exer- 
cise tolerance and minimal residual supraglottic edema 
9 months following decannulation. 
DISCUSSION 
The augmentation of radiation reactions with 
the concurrent administration of chemotherapeu- 
tic agents is a well-described phenomenon most 
commonly associated with the antineoplastic an- 
tibiotics dactinomycin and doxorubicin.‘-4 This 
phenomenon has been reported with the concur- 
rent use of chemotherapeutic agents in most sub- 
classes, including alkalating agents, cytotoxic 
agents, antineoplastic antibiotics, antimytotics, 
antimetabolites, and structural analogs. With the 
use of certain chemotherapeutic agents after the 
completion of radiotherapy, a recall phenomenon 
has been observed whereby the administration of a 
chemotherapeutic agent precipitates radiation tis- 
sue reaction within the previous radiation ports5-’ 
Various organ systems may be involved in radi- 
ation recall toxicity. Reported radiation recall ef- 
fects include radiation dermatitis, mucositis, 
esophagitis, pneumonitis, phlebitis, enteritis, and 
supraglottitis in an adult.‘~5,“-10 The severity of the 
recall reaction is variable, but is probably related 
to the dosage of both the radiation and the drug. 
Other factors such as individual susceptibility, 
nutrition, and the timing of the administration of 
the drug relative to the radiation therapy also may 
play a role.1B”~‘2 
Treatment of radiation recall reactions consists 
of the administration of corticosteroids, which of- 
ten leads to a dramatic response. Response to 
dexamethasone has been widely reported.5*g”3 
This treatment, however, was not appropriate in 
our patient since the tracheotomy bypassed the 
obstructive region. 
Cessation of the offending chemotherapeutic 
agent also may decrease the severity of the recall 
reaction It is interesting to note that our patient 
developed airway obstruction after the first dose 
of dactinomycin, which was administered after 
decannulation. She undoubtedly had supraglottic 
edema during the radiation therapy and possibly 
during the subsequent administrations of dactino- 
mycin, which would not have been diagnosed due 
to the presence of the tracheotomy. Laryngoscopy 
and neck radiographs are not routinely obtained 
during radiation and chemotherapy. 
The treatment for radiation recall supraglottitis 
consists of corticosteroids in the acute phase to 
decrease the amount of inflammation. Tissue re- 
sponse to steroids administered weeks to months 
after the initial insult is questionable. Surgical in- 
tervention should consist of tracheotomy in cases 
in which severe airway obstruction occurs. Con- 
servative epiglottectomy may be considered, us- 
ing sharp dissection or a CO, laser to “debulk” the 
obstructing supraglottic structures. Aggressive re- 
section in this area may result in postoperative 
aspiration, leading to long-term management 
problems. The role of supraglottic laryngectomy 
has not been discussed in the literature on the 
management of this particular problem. Our feel- 
ing is that such radical irreversible surgery places 
the patient at increased risk for aspiration. This 
procedure may be considered in adults who have 
adequate pulmonary reserve and understand the 
risks of aspiration associated with supraglottic la- 
ryngectomy. 
CONCLUSION 
This is the first reported case of radiation recall 
supraglottitis in a pediatric patient, attributed to 
the administration of dactinomycin for a rhabdo- 
myosarcoma of the neck and peripharyngeal 
space. With numerous new chemotherapeutic 
agents being used to treat rhabdomyosarcoma and 
other childhood sarcomas as an adjuvant with ra- 
diation therapy, it is important to realize that 
radiation toxicity may be augmented by the con- 
current administration of numerous chemothera- 
peutic agents or may recur at subsequent admin- 
istrations as a recall phenomenon. 
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